A trans rights group in Montreal has reported that McGill University’s student health clinic declined to provide hormone replacement therapy (HRT) to some American students due to concerns about potential backlash from the Trump administration. The Montreal Trans Patient Union (TPU), which advocates for trans healthcare in Montreal, has been collaborating with doctors from the Student Wellness Hub to enhance care for trans patients.
During a recent meeting in March, TPU member Emma Gimbert disclosed that doctors at the wellness hub mentioned a policy change. They stated that they would no longer prescribe HRT to American citizens under 19 years old, citing Executive Order 14187 issued by Donald Trump in January 2025. This executive order aims to prevent what it terms as “chemical and surgical mutilation” of children and carries penalties for U.S. healthcare providers offering gender-affirming care to individuals under 19.
Emma Gimbert expressed surprise at the impact of Trump’s order on McGill doctors, highlighting the unexpected influence of U.S. policies on Canadian healthcare practices. Another TPU representative at the meeting criticized the new policy, emphasizing that American laws should not dictate Canadian healthcare decisions.
At the same meeting, McGill’s medical director and administrative director, along with healthcare providers offering gender-affirming care, discussed their decision not to provide HRT to two American students under 19. The doctors cited legal advice from the Canadian Medical Protective Association (CMPA) as the basis for their actions, mentioning concerns about potential repercussions from U.S. authorities.
While McGill did not confirm the specific denial of HRT to U.S. students or clarify its policy for providing gender-affirming care to them, the university emphasized that licensed physicians make medical decisions independently. McGill stated that their doctors follow guidance from the CMPA, which maintains confidentiality regarding legal advice provided to physicians.
The TPU highlighted the potential impact of McGill’s policy on international students, emphasizing that the Student Wellness Hub is a primary resource for timely access to HRT. Trans rights advocate Celeste Trianon underscored the importance of HRT for trans individuals, explaining its physiological and psychological benefits.
Looking ahead, concerns were raised about the possible implications for future U.S. students seeking gender-affirming care at McGill. Advocates stressed the need for transparency and inclusive healthcare practices to ensure that all students have access to necessary care, irrespective of their nationality.